Hanover Labs' LIPO/trim
This article was originally published in The Tan Sheet
FDA sends Livingston, N.J. manufacturer an Aug. 9 warning letter regarding LIPO/trim tablets, which contain chromium picolinate and a blend of Micro-C-Cellulose, gelatin, Uva Ursa and oat fiber. The agency said that Hanover is marketing the product as a "misbranded" weight control drug through product labeling and advertising that calls LIPO/trim "the most effective, natural appetite control tablets available today" and "an all natural diet pill." FDA said it is "unaware of any substantial scientific evidence" that demonstrates that LIPO/trim tablets "are generally recognized as safe and effective." In May, Hanover agreed to "reassess and modify [its] advertising" following a review by the National Advertising Division of the Council of Better Business Bureaus ("The Tan Sheet" May 10, p. 13). . . .
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC